Unitedhealth Group Inc (NYSE: UNH) has experienced a decline in its stock price by -1.01 compared to its previous closing price of 494.70. However, the company has seen a fall of -0.08% in its stock price over the last five trading days. CNBC Television reported 2024-04-01 that ‘Mad Money’ host Jim Cramer takes a closer look at the laggards of the Dow Jones.
Is It Worth Investing in Unitedhealth Group Inc (NYSE: UNH) Right Now?
The price-to-earnings ratio for Unitedhealth Group Inc (NYSE: UNH) is above average at 20.53x. The 36-month beta value for UNH is also noteworthy at 0.54. There are mixed opinions on the stock, with 11 analysts rating it as a “buy,” 11 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for UNH is 920.26M, and at present, short sellers hold a 0.79% of that float. The average trading volume of UNH on April 02, 2024 was 4.07M shares.
UNH’s Market Performance
UNH stock saw a decrease of -0.08% in the past week, with a monthly decline of -0.79% and a quarterly a decrease of -6.71%. The volatility ratio for the week is 1.38%, and the volatility levels for the last 30 days are 1.58% for Unitedhealth Group Inc (UNH). The simple moving average for the last 20 days is 0.54% for UNH’s stock, with a simple moving average of -3.78% for the last 200 days.
Analysts’ Opinion of UNH
Many brokerage firms have already submitted their reports for UNH stocks, with Barclays repeating the rating for UNH by listing it as a “Overweight.” The predicted price for UNH in the upcoming period, according to Barclays is $551 based on the research report published on March 06, 2024 of the current year 2024.
HSBC Securities, on the other hand, stated in their research note that they expect to see UNH reach a price target of $480, previously predicting the price at $550. The rating they have provided for UNH stocks is “Reduce” according to the report published on December 18th, 2023.
UBS gave a rating of “Buy” to UNH, setting the target price at $640 in the report published on October 16th of the previous year.
UNH Trading at -2.56% from the 50-Day Moving Average
After a stumble in the market that brought UNH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.72% of loss for the given period.
Volatility was left at 1.58%, however, over the last 30 days, the volatility rate increased by 1.38%, as shares surge +0.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.16% lower at present.
During the last 5 trading sessions, UNH fell by -0.08%, which changed the moving average for the period of 200-days by -0.33% in comparison to the 20-day moving average, which settled at $487.07. In addition, Unitedhealth Group Inc saw -6.98% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at UNH starting from McSweeney Erin, who sale 1,236 shares at the price of $483.48 back on Mar 08 ’24. After this action, McSweeney Erin now owns 9,364 shares of Unitedhealth Group Inc, valued at $597,582 using the latest closing price.
ROOS THOMAS E, the Chief Accounting Officer of Unitedhealth Group Inc, sale 858 shares at $525.79 during a trade that took place back on Feb 23 ’24, which means that ROOS THOMAS E is holding 32,289 shares at $451,128 based on the most recent closing price.
Stock Fundamentals for UNH
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- -1.52 for the gross margin
The net margin for Unitedhealth Group Inc stands at 0.06. The total capital return value is set at 0.18. Equity return is now at value 26.88, with 8.47 for asset returns.
Based on Unitedhealth Group Inc (UNH), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.46. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 9.97.
Currently, EBITDA for the company is 36.33 billion with net debt to EBITDA at 1.22. When we switch over and look at the enterprise to sales, we see a ratio of 1.33. The receivables turnover for the company is 9.49for trailing twelve months and the total asset turnover is 1.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.79.
Conclusion
In summary, Unitedhealth Group Inc (UNH) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
